These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A). Li Z; Ding L; Li Z; Wang Z; Suo F; Shen D; Zhao T; Sun X; Wang J; Liu Y; Ma L; Zhao B; Geng P; Yu B; Zheng Y; Liu H Acta Pharm Sin B; 2019 Jul; 9(4):794-808. PubMed ID: 31384539 [TBL] [Abstract][Full Text] [Related]
4. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Schmidt DM; McCafferty DG Biochemistry; 2007 Apr; 46(14):4408-16. PubMed ID: 17367163 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Substrate-Derived Spermine Oxidase Inhibitor. Dunston TT; Khomutov MA; Gabelli SB; Stewart TM; Foley JR; Kochetkov SN; Khomutov AR; Casero RA Acta Naturae; 2020; 12(3):140-144. PubMed ID: 33173604 [TBL] [Abstract][Full Text] [Related]
7. Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase. Di Paolo ML; Cervelli M; Mariottini P; Leonetti A; Polticelli F; Rosini M; Milelli A; Basagni F; Venerando R; Agostinelli E; Minarini A J Enzyme Inhib Med Chem; 2019 Dec; 34(1):740-752. PubMed ID: 30829081 [TBL] [Abstract][Full Text] [Related]
8. A mechanism-based inactivator for histone demethylase LSD1. Culhane JC; Szewczuk LM; Liu X; Da G; Marmorstein R; Cole PA J Am Chem Soc; 2006 Apr; 128(14):4536-7. PubMed ID: 16594666 [TBL] [Abstract][Full Text] [Related]
10. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening. Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512 [TBL] [Abstract][Full Text] [Related]
11. [1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio)urea moiety as a novel scaffold for LSD1 inhibitors. Li ZH; Ma JL; Liu GZ; Zhang XH; Qin TT; Ren WH; Zhao TQ; Chen XH; Zhang ZQ Eur J Med Chem; 2020 Feb; 187():111989. PubMed ID: 31881456 [TBL] [Abstract][Full Text] [Related]
12. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Yang M; Culhane JC; Szewczuk LM; Jalili P; Ball HL; Machius M; Cole PA; Yu H Biochemistry; 2007 Jul; 46(27):8058-65. PubMed ID: 17569509 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic analysis of a suicide inactivator of histone demethylase LSD1. Szewczuk LM; Culhane JC; Yang M; Majumdar A; Yu H; Cole PA Biochemistry; 2007 Jun; 46(23):6892-902. PubMed ID: 17511474 [TBL] [Abstract][Full Text] [Related]
16. Controlling the regioselectivity and stereospecificity of FAD-dependent polyamine oxidases with the use of amine-attached guide molecules as conformational modulators. Keinänen TA; Grigorenko N; Khomutov AR; Huang Q; Uimari A; Alhonen L; Hyvönen MT; Vepsäläinen J Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30006473 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Huang Y; Greene E; Murray Stewart T; Goodwin AC; Baylin SB; Woster PM; Casero RA Proc Natl Acad Sci U S A; 2007 May; 104(19):8023-8. PubMed ID: 17463086 [TBL] [Abstract][Full Text] [Related]
18. 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1. Wu F; Zhou C; Yao Y; Wei L; Feng Z; Deng L; Song Y J Med Chem; 2016 Jan; 59(1):253-263. PubMed ID: 26652247 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A. Mimasu S; Sengoku T; Fukuzawa S; Umehara T; Yokoyama S Biochem Biophys Res Commun; 2008 Feb; 366(1):15-22. PubMed ID: 18039463 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]